ArticleThe Lancet regional health. Western Pacific2023

Efficacy and safety of ainuovirine versus efavirenz combination therapies with lamivudine/tenofovir disoproxil fumarate for medication of treatment-naïve HIV-1-positive adults: week 48 results of a randomized controlled phase 3 clinical trial followed by an open-label setting until week 96.

Bin Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.